MUSCLE LOSS DURING NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITHIN THE PREOPANC-2 STUDY PREDICTS OVERALL SURVIVAL

Sep 7, 2026 — 11:33 am - 11:42 AM
Convention Hall A

Main Session
Presenter:
Nicole HILDEBRAND (Germany)

Parent session